Clinical trial
Safety and Efficacy of Cardiac Shockwave Therapy in Patients Undergoing Coronary Artery Bypass Grafting
NCT03859466 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Cardiac Shockwave Therapy in Patients Undergoing Coronary Artery Bypass Grafting
- Lead sponsor
- Medical University Innsbruck
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 16, 2018
- Completion date
- March 15, 2023
- Enrollment
- 63 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac ischemia, heart failure patients